Silver’s parabolic rally has taken the precious metal to a level that historically signals a meaningful move lower is ahead, ...

In just three years, generative artificial intelligence has gone from a fringe Silicon Valley novelty to a household name.

Gold and silver were seeing some profit-taking to kick off the final week of 2025, but the bond market has been an "island of calm," according to Bob Savage, head of markets macro strategy at BNY. The ...

The Halda deal aims to bolster the healthcare company's oncology pipeline. With the buy, Johnson & Johnson adds to its portfolio Halda's lead candidate, HLD-0915, a once-daily therapy for prostate ...

The Cboe Volatility Index, also known as the "VIX" or Wall Street's "fear gauge," spiked Monday morning after touching its lowest level in more than a year last week. The VIX was up 9% at 14.83 ...

Ultragenyx Pharmaceutical and Mereo BioPharma said their two Phase 3 trials for setrusumab to treat rare bone disorder osteogenesis imperfecta, didn't meet their main goal of reducing fracture rates.